[Therapy of female hirsutism: current status and new findings].
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000312:Adrenal Hyperplasia, Congenital / Q000188:drug therapy; D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens / Q000378:metabolism; D001971:Bromocriptine / Q000008:administration & dosage; D002927:Cimetidine / Q000008:administration & dosage; D003534:Cyproterone / Q000008:administration & dosage / Q000031:analogs & derivatives; D017373:Cyproterone Acetate; D004338:Drug Combinations; D045166:Estradiol Congeners / Q000008:administration & dosage; D005260:Female; D006628:Hirsutism / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy; D045167:Progesterone Congeners / Q000008:administration & dosage; D013148:Spironolactone / Q000008:administration & dosage; D013970:Thyronines / Q000008:administration & dosage; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000726:Androgen Antagonists; D000728:Androgens; D004338:Drug Combinations; D045166:Estradiol Congeners; D045167:Progesterone Congeners; D013970:Thyronines; C013068:3-monoiodothyronine; D013148:Spironolactone; D001971:Bromocriptine; D017373:Cyproterone Acetate; D002927:Cimetidine; D003534:Cyproterone
Terapia dell'irsutismo femminile: messa a punto e nuove acquisizioni.